This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pharmacology
[{'content': "Lutetium dotatate was approved by FDA in 2018 for \nSelect and explain. \nA. TB, B. Neuroendocrine tumours, C. Crohn's disease, D. Peptic ulcer", 'role': 'user'}, {'content': 'Answer: B \nExplanation: Lutetium (Lu 177) dotatate a radiolabeled somatostatin analogue, for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumours in adults.', 'role': 'assistant'}]